AU745000B2 - Multilamellar coalescence vesicles (MLCV) containing biologically active compounds - Google Patents

Multilamellar coalescence vesicles (MLCV) containing biologically active compounds Download PDF

Info

Publication number
AU745000B2
AU745000B2 AU96800/98A AU9680098A AU745000B2 AU 745000 B2 AU745000 B2 AU 745000B2 AU 96800/98 A AU96800/98 A AU 96800/98A AU 9680098 A AU9680098 A AU 9680098A AU 745000 B2 AU745000 B2 AU 745000B2
Authority
AU
Australia
Prior art keywords
biologically active
mlcvs
active compound
vesicles
suvs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU96800/98A
Other languages
English (en)
Other versions
AU9680098A (en
Inventor
Michael M. Batenjany
Lawrence T Boni
Stella Gevantmakher
Mircea C. Popescu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncothyreon Canada Inc
Original Assignee
Biomira USA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomira USA Inc filed Critical Biomira USA Inc
Publication of AU9680098A publication Critical patent/AU9680098A/en
Application granted granted Critical
Publication of AU745000B2 publication Critical patent/AU745000B2/en
Assigned to BIOMIRA INC. reassignment BIOMIRA INC. Alteration of Name(s) in Register under S187 Assignors: BIOMIRA USA INC.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y10S977/907—Liposome

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU96800/98A 1997-10-01 1998-10-01 Multilamellar coalescence vesicles (MLCV) containing biologically active compounds Ceased AU745000B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6060697P 1997-10-01 1997-10-01
US60/060606 1997-10-01
PCT/US1998/020780 WO1999016426A2 (en) 1997-10-01 1998-10-01 Multilamellar coalescence vesicles (mlcv) containing biologically active compounds

Publications (2)

Publication Number Publication Date
AU9680098A AU9680098A (en) 1999-04-23
AU745000B2 true AU745000B2 (en) 2002-03-07

Family

ID=22030591

Family Applications (1)

Application Number Title Priority Date Filing Date
AU96800/98A Ceased AU745000B2 (en) 1997-10-01 1998-10-01 Multilamellar coalescence vesicles (MLCV) containing biologically active compounds

Country Status (9)

Country Link
US (1) US6544549B1 (enExample)
EP (1) EP1019026B1 (enExample)
JP (1) JP2001517693A (enExample)
AT (1) ATE286717T1 (enExample)
AU (1) AU745000B2 (enExample)
CA (1) CA2305533C (enExample)
DE (1) DE69828624T2 (enExample)
IN (1) IN190388B (enExample)
WO (1) WO1999016426A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006095798A1 (ja) * 2005-03-09 2006-09-14 Sunstar Inc. フィトステロールを含んだリポソームを含有する抗癌用経口組成物、該リポソームによる癌の予防又は治療
US7662405B2 (en) * 2005-08-09 2010-02-16 The Research Foundation Of State University Of New York Compositions and methods of preparation of liposomal microparticulate IL-12
US20140271782A1 (en) 2013-03-15 2014-09-18 Dermazone Solutions, Inc. Method for preparing nanolipids with encapsulated alcohol
US8597678B2 (en) 2005-12-30 2013-12-03 Dermazone Solutions, Inc. Nanolipidic particles
WO2010059253A2 (en) 2008-11-24 2010-05-27 Massachusets Institute Of Technology Methods and compositions for localized agent delivery
US20100324124A1 (en) * 2009-06-17 2010-12-23 Massachusetts Institute Of Technology Compositions and methods relating to DNA-based particles
US20100323018A1 (en) * 2009-06-17 2010-12-23 Massachusetts Institute Of Technology Branched DNA/RNA monomers and uses thereof
EP2547327B1 (en) * 2010-03-19 2018-09-05 Massachusetts Institute of Technology Lipid vesicle compositions and methods of use
US9149432B2 (en) 2010-03-19 2015-10-06 Massachusetts Institute Of Technology Lipid vesicle compositions and methods of use
US20110229556A1 (en) * 2010-03-19 2011-09-22 Massachusetts Institute Of Technology Lipid-coated polymer particles for immune stimulation
CN102654505A (zh) * 2012-05-16 2012-09-05 江苏省原子医学研究所 一种检测il-2-hsa的时间分辨荧光免疫分析试剂盒及其检测方法
DK2925297T3 (en) * 2012-11-02 2017-10-02 Cytuvax COMPOSITION COMPREHENSIVE CYTOCHINE MACROAGGERATES
US9770415B2 (en) * 2012-11-27 2017-09-26 Southwest Research Institute Delivery substrates from aligned polymer biomaterials for tissue repair
EP3049114B1 (en) 2013-09-27 2021-11-10 Massachusetts Institute of Technology Carrier-free biologically-active protein nanostructures
PT3291797T (pt) 2015-05-04 2020-10-19 Versantis AG Método para preparar vesículas de gradiente de ph transmembranar
US11034752B2 (en) 2015-08-12 2021-06-15 Massachusetts Institute Of Technology Cell surface coupling of nanoparticles
CA3029813A1 (en) 2016-06-13 2017-12-21 Torque Therapeutics, Inc. Methods and compositions for promoting immune cell function
WO2019050978A1 (en) 2017-09-05 2019-03-14 Torque Therapeutics, Inc. THERAPEUTIC PROTEIN COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF
US11020355B2 (en) 2018-09-06 2021-06-01 NuVessl, Inc. Method of encapsulating cannabinoids in phospholipid carriers
US20200188301A1 (en) 2018-12-14 2020-06-18 NuVessl, Inc. Method for Enhancing Passenger Molecule Loading
WO2021158996A1 (en) * 2020-02-05 2021-08-12 University Of Florida Research Foundation, Incorporated Rna-loaded nanoparticles and use thereof for the treatment of cancer
US20240285791A1 (en) * 2020-09-04 2024-08-29 Daegu Gyeongbuk Institute Of Science And Technology Extracellular vesicle expressing cytokine and antibody, method for producing same, and use thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997029769A1 (en) * 1996-02-16 1997-08-21 Biomira Usa Inc. Vaccine for b-cell malignancies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04356421A (ja) * 1991-03-06 1992-12-10 Green Cross Corp:The プロスタグランジン類含有脂肪小体組成物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997029769A1 (en) * 1996-02-16 1997-08-21 Biomira Usa Inc. Vaccine for b-cell malignancies

Also Published As

Publication number Publication date
DE69828624D1 (de) 2005-02-17
EP1019026A2 (en) 2000-07-19
ATE286717T1 (de) 2005-01-15
AU9680098A (en) 1999-04-23
CA2305533A1 (en) 1999-04-08
JP2001517693A (ja) 2001-10-09
DE69828624T2 (de) 2005-12-22
WO1999016426A2 (en) 1999-04-08
EP1019026B1 (en) 2005-01-12
CA2305533C (en) 2009-12-01
US6544549B1 (en) 2003-04-08
WO1999016426A3 (en) 1999-06-17
IN190388B (enExample) 2003-07-26

Similar Documents

Publication Publication Date Title
AU745000B2 (en) Multilamellar coalescence vesicles (MLCV) containing biologically active compounds
EP0524968B1 (en) Heterovesicular liposomes
US5616334A (en) Low toxicity drug-lipid systems
EP0713388B1 (en) A method for high loading of vesicles with biopolymeric substances
CA1315678C (en) Alpha-tocopherol based vesicles
US5049392A (en) Osmotically dependent vesicles
AU741784B2 (en) Modulation of drug loading in multivesicular liposomes
US6406713B1 (en) Methods of preparing low-toxicity drug-lipid complexes
US5723147A (en) Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
JP3571717B2 (ja) 粒子、該粒子の製法及びその使用
US6066331A (en) Method for preparation of vesicles loaded with biological structures, biopolymers and/or oligomers
EP0280503B9 (en) Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
EP0349579B1 (en) Lipid vesicles formed of surfactants and steroids
CA2436348A1 (en) Preparation of large liposomes by infusion into peg
CN1044093C (zh) 低毒性药物类脂制剂
US5173219A (en) Uniform spherical multilamellar liposomes of defined and adjustable size distribution
US4873089A (en) Proteoliposomes as drug carriers
EP1523977A1 (en) Multilamellar coalescence vesicles (MLCV) containing biologically active compounds
EP0713387B1 (en) A method for preparation of vesicles loaded with biological structures, biopolymers and/or oligomers
DE69408852T2 (de) Herstellungsverfahren von mit biologischen strukturen, biopolymeren und/oder oligomeren beladenen vesikeln
Venkatesh A review on: Liposomes
Reddy et al. International Journal of Indigenous Herbs and Drugs
Stricker Phospholipid Liposomes as Drug Carriers: Preparation and Properties

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)